Betiatide is a synthetic oligopeptide therapeutic currently under investigation for its potential to modulate renal inflammation in the treatment of chronic kidney disease and acute kidney injury. This… Read more
Betiatide is a synthetic oligopeptide therapeutic currently under investigation for its potential to modulate renal inflammation in the treatment of chronic kidney disease and acute kidney injury. This category encompasses a comprehensive selection of Betiatide reference standards, including the active pharmaceutical ingredient, its related impurities, and metabolites. Analytical laboratories rely on these high-quality compounds for essential processes such as impurity profiling, method validation, and the development of robust quality control protocols. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for precise quantitative bioanalysis, allowing researchers to accurately monitor drug concentrations and degradation pathways during pharmaceutical development. These reference materials support the stringent regulatory requirements necessary for verifying the purity and stability of this investigational peptide in complex biological and chemical matrices.